Gilead is expected to enhance its efficiency through leveraging Cognizant’s expertise in AI and advanced technology ...

According to CEO: ‘Demand across the industry not meeting our expectations.’ ...

I-MAB completed a workforce reduction as part of a Realignment Plan aimed at optimizing its operations following the pipeline reprioritization. The company reduced its workforce by approximately 27% ...

The approval is based on results from the Phase III FLOW trial demonstrating Ozempic reduced the risk of severe kidney outcomes by 24% compared to placebo, including kidney failure, reduction in ...

CS Analytical Laboratory, an FDA-regulated contract laboratory dedicated to providing regulatory solutions and qualification ...

UK contract development and manufacturing organization Upperton Pharma Solutions has completed the build of its new sterile ...

Schrödinger, a global leader in computational chemistry, has adopted the Sapio Sciences Platform to improve data management, ...

New approval brings the medicine to an earlier treatment setting and a broader patient population.

The U.S. Food and Drug Administration (FDA) has granted 510 (k) clearance for Fresenius Kabi’s Adaptive Nomogram, an ...

Kenox Pharmaceuticals Inc., a company dedicated to developing innovative Orally Inhaled and Nasal Drug Products (OINDPs), has ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, has opened its Center of Excellence for ...